36 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain regulatory
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
to recoup our investment in one or more planned products, even if our planned products obtain regulatory approval.
Our ability to commercialize our
424B5
4isq93erokqbe03vvr5
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
17imgt3m 5xc
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
7xjms0y
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
heyerhn53q amz58pk
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
0kiyhwlp o71rxr3a5b
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
fna93q0t7wixwwee
12 Apr 19
Prospectus supplement
4:41pm